Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Tax Rate (2017 - 2025)

Corcept Therapeutics' Tax Rate history spans 9 years, with the latest figure at 144.94% for Q4 2025.

  • For Q4 2025, Tax Rate fell 14865.0% year-over-year to 144.94%; the TTM value through Dec 2025 reached 49.94%, down 6243.0%, while the annual FY2025 figure was 49.94%, 6250.0% down from the prior year.
  • Tax Rate for Q4 2025 was 144.94% at Corcept Therapeutics, down from 29.03% in the prior quarter.
  • Across five years, Tax Rate topped out at 31.61% in Q4 2022 and bottomed at 144.94% in Q4 2025.
  • The 5-year median for Tax Rate is 13.93% (2023), against an average of 5.26%.
  • The largest annual shift saw Tax Rate soared 3311bps in 2022 before it crashed -14865bps in 2025.
  • A 5-year view of Tax Rate shows it stood at 12.78% in 2021, then skyrocketed by 147bps to 31.61% in 2022, then tumbled by -54bps to 14.69% in 2023, then tumbled by -75bps to 3.7% in 2024, then plummeted by -4013bps to 144.94% in 2025.
  • Per Business Quant, the three most recent readings for CORT's Tax Rate are 144.94% (Q4 2025), 29.03% (Q3 2025), and 11.04% (Q2 2025).